Effectiveness of Algan Hemostatic Agent in Bleeding Control: An Experimental Kidney Incision Model

Basit Öğe Kaydı
dc.authoridEkici, Husamettin/0000-0001-6403-737X
dc.authoridMidi, Ahmet/0000-0002-6197-7654
dc.authoridKUMANDAS, ALI/0000-0002-7679-2126
dc.contributor.authorMidi, Ahmet
dc.contributor.authorKumandas, Ali
dc.contributor.authorEkici, Husamettin
dc.contributor.authorKilic, Yusuf
dc.contributor.authorOzgocmen, Ruchan
dc.date.accessioned2025-01-21T16:34:17Z
dc.date.available2025-01-21T16:34:17Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstractAim: The purpose of this study is to evaluate the hemostatic efficacy of a novel plant originated blood stopper which is called Algan Hemostatic Agent (AHA) in uncontrolled kidney incision bleeding model. Methods: The study was conducted with thirty-two rats 5-7 weeks old. The rats were randomly divided into 4 groups, each consisting of eight rats (Group 1: heparinized saline, 2: heparinized AHA, 3: non-heparinized saline, 4: non-heparinized AHA). Experimental kidney incision was made, and saline soaked sponge was applied to the control group and AHA to the study group. Results: The duration of bleeding was significantly shorter in the AHA group compared to the control group. The AHA has controlled the bleeding in the heparinized and non-heparinized groups 5 +/- 1.19 and 3 +/- 0.91 seconds respectively (p<0.001). In the control group, hemorrhage was controlled in the heparinized and non-heparinized group 180.6 +/- 25.4 and 125.4 +/- 21 seconds respectively. Conclusion: This study demonstrated that the AHA is useful in controlling bleeding in the Rat kidney incision model.
dc.description.sponsorshipAlgan Group Health Services (Algan Group Health Services Import and Export Industry and Trade Limited Company, Istanbul, Turkey)
dc.description.sponsorshipThis study supported by The Algan Group Health Services (Algan Group Health Services Import and Export Industry and Trade Limited Company, Istanbul, Turkey). The company had been role of the study materials provided for scientists, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
dc.identifier.doi10.4274/haseki.galenos.2021.6506
dc.identifier.endpage47
dc.identifier.issn1302-0072
dc.identifier.issn2147-2688
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85101311748
dc.identifier.scopusqualityQ3
dc.identifier.startpage43
dc.identifier.trdizinid424534
dc.identifier.urihttps://doi.org/10.4274/haseki.galenos.2021.6506
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay424534
dc.identifier.urihttps://hdl.handle.net/20.500.12587/23937
dc.identifier.volume59
dc.identifier.wosWOS:000658757400007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofHaseki Tip Bulteni-Medical Bulletin of Haseki
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectAlgan hemostatic agent; hemostasis; rats; kidney; bleeding
dc.titleEffectiveness of Algan Hemostatic Agent in Bleeding Control: An Experimental Kidney Incision Model
dc.title.alternativeAlgan hemostatik ajanın kanama kontrolündeki etkinliği: Deneysel bir böbrek insizyon modeli
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu